Don’t miss outtag icon
Get early access to Digital 100 2026, Similarweb’s official ranking of the fastest-growing brandsPre-register now!banner icon
Otezla

November 2025

Otezla Market Share Analysis for November 2025

Otezla® is a pill that helps treat some symptoms of plaque psoriasis, psoriatic arthritis, and oral ulcers in BD. See full prescribing and safety info.
Year Founded--
Employees51 - 200
Annual Revenue$15M - $25M
otezla.com
Otezla
Otezla (including company regionals)
  • otezla.com
    otezla.com
See more website traffic and engagement information

Otezla Revenue up to November 2025 is 15M - 25M

revenue generated by Otezla top domains

Otezla top domains revenue over 3 years

Revenue for Otezla top domains


Total visits to Otezla's top domains

Understand Otezla market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Otezla's top domains

Analyze Otezla engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Otezla's top domains

See how Otezla keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Otezla

These are the website technologies, by industry, used by Otezla top domains

Advertising (20)

DoubleClick

DoubleClick

Audio Video Media (5)

Vimeo

Vimeo

Conversion & Analytics (5)

Google Analytics

Google Analytics

Social (5)

Instagram

Instagram

More Technologies

7

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Otezla

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBristolmyerslaw acquired Otezla for $74B on Jan 1st '19.Bristol Myers acquired Otezla when it bought Celgene for $74 billion in 2019.
NewsCelgene Corp. sold assets to Otezla on Jan 1st '19.The FTC required Bristol-Myers and Celgene sell the rights to Otezla, Celgene's psoriasis drug.

See all Otezla signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.